VIEWPOINTS


Viewpoints are a collection of news and opinion articles that capture key research developments and important issues in the field of oncology.


In Focus: Cabozantinib for Renal Cell Carcinoma

In Focus: Cabozantinib for Renal Cell Carcinoma

Ongoing studies are expected to provide information about how to sequence cabozantinib in clinical practice.

Breast Cancer Risk Higher in Men Previously Treated for Lymphoma According to Research

Breast Cancer Risk Higher in Men Previously Treated for Lymphoma According to Research

Researchers found that, among men previously treated for lymphoma, the incidence of breast cancer is higher than in the general population.

Q&A With Keith Flaherty, MD: Dabrafenib and Trametinib for Melanoma

Q&A With Keith Flaherty, MD: Dabrafenib and Trametinib for Melanoma

Cancer Therapy Advisor interviewed Keith Flaherty, MD, about recent findings regarding targeted therapies for melanoma.

Prostate Cancer Treatment: Abiraterone and Other Hormonal Therapies Being Studied

Prostate Cancer Treatment: Abiraterone and Other Hormonal Therapies Being Studied

More studies are needed to define the role of intratumoral androgen production and mCRPC resistance to hormonal therapies, and to determine if inhibitors of other steroidogenesis enzymes can be synergistic with abiraterone.

Immune Checkpoint Inhibitors: Treatment Efficacy in Elderly Patients With Melanoma

Immune Checkpoint Inhibitors: Treatment Efficacy in Elderly Patients With Melanoma

Immune checkpoint inhibitors may be effective for treating elderly patients with melanoma without dramatically increasing toxicity.

Lung Cancer Treatment Shows Promise With TG4010 and CIMAvax-EGF Vaccine Therapies

Lung Cancer Treatment Shows Promise With TG4010 and CIMAvax-EGF Vaccine Therapies

Two vaccine therapies, TG4010 and CIMAvax-EGF, show promise for treating lung cancer. Developed and approved for use in Cuba, CIMAvax-EGF is now undergoing clinical study in the United States.

Pembrolizumab May Effectively Treat Mediastinal B Cell Lymphoma

Pembrolizumab May Effectively Treat Mediastinal B Cell Lymphoma

Pembrolizumab may be an effective treatment for patients with a rare subtype of diffuse large B-cell lymphoma, which usually carries a poor prognosis.

Q&A With Matthew Rabinowitz, PhD: Detecting Relapse by Liquid Biopsy

Q&A With Matthew Rabinowitz, PhD: Detecting Relapse by Liquid Biopsy

Cancer Therapy Advisor asked Dr Rabinowitz, founder and CEO of Natera, about the bespoke PCR technology and ongoing studies.

Glioblastoma Survival Rates May Improve With New Immunotherapeutic Approach

Glioblastoma Survival Rates May Improve With New Immunotherapeutic Approach

New immunotherapeutic approaches, such as dendritic cell vaccination, may be effective for treating this rare brain cancer, which is associated with dismal survival rates.

Hodgkin Lymphoma: Risk-adapted Therapy Recommended

Hodgkin Lymphoma: Risk-adapted Therapy Recommended

Long-term follow-up data from randomized trials on Hodgkin lymphoma support current risk-adapted therapeutic approaches for early-stage disease.

Nutritional Challenges in Patients Post-Whipple Surgery

Nutritional Challenges in Patients Post-Whipple Surgery

Nutrition is a critical factor to consider both in the pre- and postoperative period for patients undergoing a Whipple procedure.

Random Mutations May Be Leading Cause of Oncogenesis

Random Mutations May Be Leading Cause of Oncogenesis

According to a study across all 32 cancer types, data suggest that 66% of mutations leading to cancer are the result of random events.

Bladder Cancer Treatment Is Being Revolutionized by Immunotherapy

Bladder Cancer Treatment Is Being Revolutionized by Immunotherapy

Clinical trials and drug approvals in the past several years have dramatically improved bladder cancer treatment.

Periodontal Disease: A Risk Factor for Non-Hodgkin Lymphoma?

Periodontal Disease: A Risk Factor for Non-Hodgkin Lymphoma?

More studies are needed to determine the association between periodontal disease and non-Hodgkin lymphoma.

Maintenance Rituximab for Follicular Lymphoma

Maintenance Rituximab for Follicular Lymphoma

A recent meta-analysis including patients from 7 trials shows that MR improves overall survival among all patients regardless of patient and disease characteristics.

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters